| 1 | CCND1, USP27X
|
| Regulation of Cyclin D1 Degradation by Ubiquitin-Specific Protease 27X Is Critical for Cancer Cell Proliferation and Tumor Growth
|
| Alam S, Zunic A, Venkat S, Feigin ME, Atanassov BS
|
| Mol Cancer Res. Dec 2;20(12):1751-1762. doi: 10.1158/1541-7786.MCR-22-0259. 2022
|
| 2 | CCND1, CDKN1A, NFIC
|
| NFI-C Is Required for Epiphyseal Chondrocyte Proliferation during Postnatal Cartilage Development.
|
| Lee DS, Roh SY, Choi H, Park JC.
|
| Mol Cells. Aug 31;43(8):739-748. doi: 10.14348/molcells.2020.2272. 2020
|
| 3 | CCND1, tCEAL7
|
| Downregulation of TCEAL7 expression induces CCND1 expression in non-small cell lung cancer.
|
| Orhan C, Bulut P, Dalay N, Ersen E, Buyru N.
|
| Mol Biol Rep 46(5):5251-5256. doi: 10.1007/s11033-019-04982-6. Epub 2019 Jul 18.
2019
|
| 4 | ADD1, CCND1, ZNF322
|
| AKT-mediated phosphorylation enhances protein stability and transcription activity of ZNF322A to promote lung cancer progression
|
| Liao SY, Kuo IY, Chen YT, Liao PC, Liu YF, Wu HY, Lai WW, Wang YC.
|
| Oncogene Oct;38(41):6723-6736. doi: 10.1038/s41388-019-0928-x. Epub 2019 Aug 9. 2019
|
| 5 | CCND1, CDK4, SHCBP1
|
| SHCBP1 is a novel target and exhibits tumor‑promoting effects in gastric cancer.
|
| Dong YD, Yuan YL, Yu HB, Tian GJ, Li DY.
|
| Oncol Rep Mar;41(3):1649-1657. doi: 10.3892/or.2018.6952. Epub 2018 Dec 21 2018
|
| 6 | CCND1, CCNE1, CDK2, CDK4, CIAPIN1
|
| The study on expression of CIAPIN1 interfering hepatocellular carcinoma cell proliferation and its mechanisms.
|
| Huang Z, Su GF, Hu WJ, Bi XX, Zhang L, Wan G.
|
| Eur Rev Med Pharmacol Sci 21(13):3054-3060.
2017
|
| 7 | CCND1, MYF5
|
| Novel RNA-binding activity of MYF5 enhances Ccnd1/Cyclin D1 mRNA translation during myogenesis.
|
| Panda AC, Abdelmohsen K, Martindale JL, Di Germanio C, Yang X, Grammatikakis I, Noh JH, Zhang Y, Lehrmann E, Dudekula DB, De S, Becker KG, White EJ, Wilson GM, de Cabo R, Gorospe M.
|
| Nucleic Acids Res 44(5):2393-408. doi: 10.1093/nar/gkw023. Epub 2016 Jan 26.
2016
|
| 8 | CCND1, CDC42BPA
|
| Discovery and characterization of a novel CCND1/MRCK gene fusion in mantle cell lymphoma.
|
| Masamha CP, Albrecht TR, Wagner EJ.
|
| J Hematol Oncol 9:30. doi: 10.1186/s13045-016-0260-7.
2016
|
| 9 | CCND1, CLDN16, CPE, LRP1B, MAGI3, MAPK6, MATN2, MPPED2, PFKFB2, PTPRE, PYGL, SEMA3D, SERGEF, SLC4A4, TIMP1
|
| robust biomarker of differential correlations improves the diagnosis of cytologically indeterminate thyroid cancers
|
| Gomez-Rueda H, Palacios-Corona R, Gutiérrez-Hermosillo H, Trevino V. A
|
| Int J Mol Med. May;37(5):1355-62. doi: 10.3892/ijmm.2016.2534. Epub 2016 Mar 2016
|
| 10 | CCND1, CCND3, CCNG1, HNRNPM, IGF2BP3
|
| Post-transcriptional regulation of cyclins D1, D3 and G1 and proliferation of human cancer cells depend on IMP-3 nuclear localization.
|
| Rivera Vargas T, Boudoukha S, Simon A, Souidi M, Cuvellier S, Pinna G, Polesskaya A.
|
| Oncogene 33(22):2866-75. doi: 10.1038/onc.2013.252. Epub 2013 Jul 1. 2014
|
| 11 | CCND1, CCNE1, CSF2
|
| GM-CSF induces cyclin D1 expression and proliferation of endothelial progenitor cells via PI3K and MAPK signaling.
|
| Qiu C, Xie Q, Zhang D, Chen Q, Hu J, Xu L.
|
| Cell Physiol Biochem 33(3):784-95. doi: 10.1159/000358652. Epub 2014 Mar 7.
2014
|
| 12 | BCL2A1, CCND1
|
| Up-regulation of cyclinD1 and Bcl2A1 by insulin is involved in osteoclast proliferation.
|
| Lee JY, Lee NK.
|
| Life Sci. Oct 2;114(2):57-61. doi: 10.1016/j.lfs.2014.07.006. Epub 2014 Jul 24 2014
|
| 13 | CCND1
|
| Cyclin D1 overexpression perturbs DNA replication and induces replication-associated DNA double-strand breaks in acquired radioresistant cells.
|
| Shimura T, Ochiai Y, Noma N, Oikawa T, Sano Y, Fukumoto M.
|
| Cell Cycle 12(5). [Epub ahead of print]
2013
|
| 14 | BIRC5, CCND1, POU5F1
|
| OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma.
|
| Cao L, Li C, Shen S, Yan Y, Ji W, Wang J, Qian H, Jiang X, Li Z, Wu M, Zhang Y, Su C.
|
| BMC Cancer 13:82. doi: 10.1186/1471-2407-13-82.
2013
|
| 15 | CCND1, PCNA, ROCK1, ROCK2
|
| Rho-associated protein kinase isoforms stimulate proliferation of vascular smooth muscle cells through ERK and induction of cyclin D1 and PCNA.
|
| Zhao Y, Lv M, Lin H, Cui Y, Wei X, Qin Y, Kohama K, Gao Y.
|
| Biochem Biophys Res Commun 432(3):488-93. doi: 10.1016/j.bbrc.2013.02.009. Epub 2013 Feb 10.
2013
|
| 16 | CCND1, CDK4, STK38, STK38L
|
| Cyclin D1 promotes cell cycle progression through enhancing NDR1/2 kinase activity independent of cyclin-dependent kinase 4.
|
| Du Z, Tong X, Ye X.
|
| J Biol Chem 288(37):26678-87. doi: 10.1074/jbc.M113.466433. Epub 2013 Jul 29.
2013
|
| 17 | CCND1, CCNE1, KDM5A
|
| Histone demethylase RBP2 promotes lung tumorigenesis and cancer metastasis.
|
| Teng YC, Lee CF, Li YS, Chen YR, Hsiao PW, Chan MY, Lin FM, Huang HD, Chen YT, Jeng YM, Hsu CH, Yan Q, Tsai MD, Juan LJ.
|
| Cancer Res 73(15):4711-21. doi: 10.1158/0008-5472.CAN-12-3165. Epub 2013 May 30.
2013
|
| 18 | CCND1, EYA1
|
| EYA1 phosphatase function is essential to drive breast cancer cell proliferation through cyclin D1.
|
| Wu K, Li Z, Cai S, Tian L, Chen K, Wang J, Hu J, Sun Y, Li X, Ertel A, Pestell RG.
|
| Cancer Res 73(14):4488-99. doi: 10.1158/0008-5472.CAN-12-4078. Epub 2013 May 1.
2013
|
| 19 | CASP3, CCND1, MMP9, NUMBL, TRAF6
|
| Numblike regulates proliferation, apoptosis, and invasion of lung cancer cell.
|
| Yingjie L, Jian T, Changhai Y, Jingbo L.
|
| Tumour Biol 34(5):2773-80. doi: 10.1007/s13277-013-0835-7. Epub 2013 May 17.
2013
|
| 20 | CCND1, CTNNB1, GLI1, SULF2, WNT1
|
| Activation of the transcription factor GLI1 by WNT signaling underlies the role of SULFATASE 2 as a regulator of tissue regeneration
|
| Nakamura I, Fernandez-Barrena MG, Ortiz-Ruiz MC, Almada LL, Hu C, Elsawa SF, Mills LD, Romecin PA, Gulaid KH, Moser CD, Han JJ, Vrabel A, Hanse EA, Akogyeram NA, Albrecht JH, Monga SPS, Sanderson SO, Prieto J, Roberts LR, Fernandez-Zapico ME.
|
| J Biol Chem. Jul 19;288(29):21389-21398. doi: 10.1074/jbc.M112.443440. Epub 2013 Jun 5. 2013
|
| 21 | CARD10, CCND1
|
| CARMA3 is overexpressed in colon cancer and regulates NF-κB activity and cyclin D1 expression.
|
| Miao Z, Zhao T, Wang Z, Xu Y, Song Y, Wu J, Xu H.
|
| Biochem Biophys Res Commun 425(4):781-7. doi: 10.1016/j.bbrc.2012.07.152. Epub 2012 Aug 2. 2012
|
| 22 | CCND1, MLXIPL
|
| Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte nuclear factor 4α.
|
| Hanse EA, Mashek DG, Becker JR, Solmonson AD, Mullany LK, Mashek MT, Towle HC, Chau AT, Albrecht JH.
|
| Cell Cycle 11(14):2681-90. doi: 10.4161/cc.21019. Epub 2012 Jul 15.
2012
|
| 23 | CCND1, CDK4, YY1
|
| Yin Yang-1 inhibits tumor cell growth and inhibits p21WAF1/Cip1 complex formation with cdk4 and cyclin D1.
|
| Ishii H, Hulett MD, Li JM, Santiago FS, Parish CR, Khachigian LM.
|
| Int J Oncol 40(5):1575-80. doi: 10.3892/ijo.2012.1362. Epub 2012 Feb 9.
2012
|
| 24 | CCND1, ISG15, USP18
|
| Evidence for the ubiquitin protease UBP43 as an antineoplastic target.
|
| Guo Y, Chinyengetere F, Dolinko AV, Lopez-Aguiar A, Lu Y, Galimberti F, Ma T, Feng Q, Sekula D, Freemantle SJ, Andrew AS, Memoli V, Dmitrovsky E.
|
| Mol Cancer Ther 11(9):1968-77. doi: 10.1158/1535-7163.MCT-12-0248. Epub 2012 Jul 2.
2012
|
| 25 | CCND1, JUN, PAX2
|
| PAX2 protein induces expression of cyclin D1 through activating AP-1 protein and promotes proliferation of colon cancer cells.
|
| Zhang HS, Yan B, Li XB, Fan L, Zhang YF, Wu GH, Li M, Fang J.
|
| J Biol Chem 287(53):44164-72. doi: 10.1074/jbc.M112.401521. Epub 2012 Nov 7.
2012
|
| 26 | CCND1, CIRBP, DYRK1B, RBM3
|
| Cold-inducible RNA-binding protein (Cirp) interacts with Dyrk1b/Mirk and promotes proliferation of immature male germ cells in mice.
|
| Masuda T, Itoh K, Higashitsuji H, Higashitsuji H, Nakazawa N, Sakurai T, Liu Y, Tokuchi H, Fujita T, Zhao Y, Nishiyama H, Tanaka T, Fukumoto M, Ikawa M, Okabe M, Fujita J.
|
| Proc Natl Acad Sci U S A 109(27):10885-90. doi: 10.1073/pnas.1121524109. Epub 2012 Jun 18.
2012
|
| 27 | CCND1, FAM60A, HDAC1, SIN3A
|
| Family with sequence similarity 60A (FAM60A) protein is a cell cycle-fluctuating regulator of the SIN3-HDAC1 histone deacetylase complex.
|
| Muñoz IM, MacArtney T, Sanchez-Pulido L, Ponting CP, Rocha S, Rouse J.
|
| J Biol Chem 287(39):32346-53.
2012
|
| 28 | CCND1, PACSIN2
|
| PACSIN 2 represses cellular migration through direct association with cyclin D1 but not its alternate splice form cyclin D1b.
|
| Meng H, Tian L, Zhou J, Li Z, Jiao X, Li WW, Plomann M, Xu Z, Lisanti MP, Wang C, Pestell RG.
|
| Cell Cycle 10(1):73-81. Epub 2011 Jan 1.
2011
|
| 29 | CCND1, SSB
|
| The RNA-binding protein La contributes to cell proliferation and CCND1 expression.
|
| Sommer G, Dittmann J, Kuehnert J, Reumann K, Schwartz PE, Will H, Coulter BL, Smith MT, Heise T.
|
| Oncogene 30(4):434-44. Epub 2010 Sep 20.
2011
|
| 30 | CCND1, SNAI2, UBE2D3
|
| SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination.
|
| Mittal MK, Singh K, Misra S, Chaudhuri G.
|
| J Biol Chem 286(1):469-79. Epub 2010 Nov 2.
2011
|
| 31 | CCND1
|
| Cyclin D1 inhibits mitochondrial activity in B cells.
|
| Tchakarska G, Roussel M, Troussard X, Sola B.
|
| Cancer Res 71(5):1690-9. Epub 2011 Feb 22.
2011
|
| 32 | CCND1, CDK4
|
| Cyclin D1 and cdk4 mediate development of neurologically destructive oligodendroglioma.
|
| Ciznadija D, Liu Y, Pyonteck SM, Holland EC, Koff A.
|
| Cancer Res 71(19):6174-83. doi: 10.1158/0008-5472.CAN-11-1031. Epub 2011 Aug 15.
2011
|
| 33 | CCND1
|
| A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers.
|
| Jirawatnotai S, Hu Y, Michowski W, Elias JE, Becks L, Bienvenu F, Zagozdzon A, Goswami T, Wang YE, Clark AB, Kunkel TA, van Harn T, Xia B, Correll M, Quackenbush J, Livingston DM, Gygi SP, Sicinski P.
|
| Nature 474(7350):230-4. doi: 10.1038/nature10155.
2011
|
| 34 | CCND1, PPFIA1
|
| PPFIA1 and CCND1 are frequently coamplified in breast cancer.
|
| Dancau AM, Wuth L, Waschow M, Holst F, Krohn A, Choschzick M, Terracciano L, Politis S, Kurtz S, Lebeau A, Friedrichs K, Wencke K, Monni O, Simon R.
|
| Genes Chromosomes Cancer 49(1):1-8.PMID: 19787783 2010
|
| 35 | CCND1, RUNX3
|
| Cyclin D1 blocks the anti-proliferative function of RUNX3 by interfering with RUNX3-p300 interaction.
|
| Iwatani K, Fujimoto T, Ito T.
|
| Biochem Biophys Res Commun 400(3):426-31. Epub 2010 Aug 27.
2010
|
| 36 | CCND1, CDC27
|
| C/EBP{delta} targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression.
|
| Pawar SA, Sarkar TR, Balamurugan K, Sharan S, Wang J, Zhang Y, Dowdy SF, Huang AM, Sterneck E.
|
| Proc Natl Acad Sci U S A 107(20):9210-5. doi: 10.1073/pnas.0913813107. Epub 2010 May 3.
2010
|
| 37 | ATM, CCND1
|
| ATM is required for rapid degradation of cyclin D1 in response to gamma-irradiation.
|
| Choo DW, Baek HJ, Motoyama N, Cho KH, Kim HS, Kim SS.
|
| Biochem Biophys Res Commun 378(4):847-50. Epub 2008 Dec 9.
2009
|
| 38 | CCND1
|
| Overrepresentation of BclI polymorphism of the glucocorticoid receptor gene in pregnant women with HELLP syndrome.
|
| Bertalan R, Patocs A, Nagy B, Derzsy Z, Gullai N, Szappanos A, Rigo J Jr, Racz K.
|
| Clin Chim Acta lin Chim Acta. 2009 Mar 28. [Epub ahead of print]
2009
|
| 39 | CCND1, INSM1
|
| Zinc finger transcription factor INSM1 interrupts cyclin D1 and CDK4 binding and induces cell cycle arrest.
|
| Zhang T, Liu WD, Saunee NA, Breslin MB, Lan MS.
|
| J Biol Chem 284(9):5574-81. Epub 2009 Jan 5.
2009
|
| 40 | CCND1
|
| Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome.
|
| Millar EK, Dean JL, McNeil CM, O'Toole SA, Henshall SM, Tran T, Lin J, Quong A, Comstock CE, Witkiewicz A, Musgrove EA, Rui H, Lemarchand L, Setiawan VW, Haiman CA, Knudsen KE, Sutherland RL, Knudsen ES.
|
| Oncogene 28(15):1812-20. Epub 2009 Mar 16.
2009
|
| 41 | FHL2, CCND1
|
| The LIM-only protein FHL2 regulates cyclin D1 expression and cell proliferation.
|
| Labalette C, Nou‘t Y, Sobczak-Thepot J, Armengol C, Levillayer F, Gendron MC, Renard CA, Regnault B, Chen J, Buendia MA, Wei Y.
|
| J Biol Chem 283(22):15201-8. Epub 2008 Mar 31. 2008
|
| 42 | CCND1, CCND2, CCND3
|
| Crucial roles of D-type cyclins in the early stage of adipocyte differentiation.
|
| Hishida T, Naito K, Osada S, Nishizuka M, Imagawa M.
|
| Biochem Biophys Res Commun 370(2):289-94. Epub 2008 Mar 27.
2008
|
| 43 | CCND1, MEN1
|
| Chromosome 11 genomic changes in parathyroid adenoma and hyperplasia: array CGH, FISH, and tissue microarrays.
|
| Yi Y, Nowak NJ, Pacchia AL, Morrison C.
|
| Genes Chromosomes Cancer 47(8):639-48.
2008
|
| 44 | CCND1
|
| Cyclin D1 in low-dose radiation-induced adaptive resistance.
|
| Ahmed KM, Fan M, Nantajit D, Cao N, Li JJ.
|
| Oncogene 27(53):6738-48. Epub 2008 Aug 11.
2008
|
| 45 | CCND1
|
| Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists.
|
| Wang Y, Dean JL, Millar EK, Tran TH, McNeil CM, Burd CJ, Henshall SM, Utama FE, Witkiewicz A, Rui H, Sutherland RL, Knudsen KE, Knudsen ES.
|
| Cancer Res 68(14):5628-38.
2008
|
| 46 | CCND1, VRK1
|
| VRK1 phosphorylates CREB and mediates CCND1 expression.
|
| Kang TH, Park DY, Kim W, Kim KT.
|
| J Cell Sci 121(Pt 18):3035-41. Epub 2008 Aug 19.
2008
|
| 47 | BRAF, CCND1
|
| BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas.
|
| Pfister S, Janzarik WG, Remke M, Ernst A, Werft W, Becker N, Toedt G, Wittmann A, Kratz C, Olbrich H, Ahmadi R, Thieme B, Joos S, Radlwimmer B, Kulozik A, Pietsch T, Herold-Mende C, Gnekow A, Reifenberger G, Korshunov A, Scheurlen W, Omran H, Lichter P.
|
| J Clin Invest 118(5):1739-49.PMID: 18398503 2008
|
| 48 | CCND1
|
| Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.
|
| Wiestner A, Tehrani M, Chiorazzi M, Wright G, Gibellini F, Nakayama K, Liu H, Rosenwald A, Muller-Hermelink HK, Ott G, Chan WC, Greiner TC, Weisenburger DD, Vose J, Armitage JO, Gascoyne RD, Connors JM, Campo E, Montserrat E, Bosch F, Smeland EB, Kvaloy S, Holte H, Delabie J, Fisher RI, Grogan TM, Miller TP, Wilson WH, Jaffe ES, Staudt LM.
|
| Blood 109(11):4599-606. Epub 2007 Feb 13. 2007
|
| 49 | CCND1, RNF14
|
| ARA54 is involved in transcriptional regulation of the cyclin D1 gene in human cancer cells.
|
| Kikuchi H, Uchida C, Hattori T, Isobe T, Hiramatsu Y, Kitagawa K, Oda T, Konno H, Kitagawa M.
|
| Carcinogenesis 28(8):1752-8. Epub 2007 May 17.
2007
|
| 50 | CCND1, ORAOV1, CTTN, SHANK2, FGF3
|
| Recurrent coamplification of cytoskeleton-associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma.
|
| Freier K, Sticht C, Hofele C, Flechtenmacher C, Stange D, Puccio L, Toedt G, Radlwimmer B, Lichter P, Joos S.
|
| Genes Chromosomes Cancer 45(2):118-25. 2006
|
| 51 | PTEN, CCND1
|
| The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation.
|
| Chung JH, Ostrowski MC, Romigh T, Minaguchi T, Waite KA, Eng C.
|
| Hum Mol Genet 15(17):2553-9. Epub 2006 Jul 18. 2006
|
| 52 | CCND1
|
| Effects of cyclin D1 (CCND1) polymorphism on susceptibility to lung cancer in a North Indian population.
|
| Sobti RC, Kaur P, Kaur S, Singh J, Janmeja AK, Jindal SK, Kishan J, Raimondi S.
|
| Cancer Genet Cytogenet 170(2):108-14.
2006
|
| 53 | CCND1
|
| Renal oncocytomas with 11q13 rearrangements: cytogenetic, molecular, and immunohistochemical analysis of cyclin D1.
|
| Jhang JS, Narayan G, Murty VV, Mansukhani MM.
|
| Cancer Genet Cytogenet 149(2):114-9. 2004
|
| 54 | SNIP1, CCND1
|
| The FHA domain protein SNIP1 is a regulator of the cell cycle and cyclin D1 expression.
|
| Roche KC, Wiechens N, Owen-Hughes T, Perkins ND.
|
| Oncogene 23(50):8185-95. 2004
|
| 55 | PTTG1, CCND1
|
| Human T-lymphotropic virus type 1 oncoprotein tax promotes unscheduled degradation of Pds1p/securin and Clb2p/cyclin B1 and causes chromosomal instability.
|
| Liu B, Liang MH, Kuo YL, Liao W, Boros I, Kleinberger T, Blancato J, Giam CZ.
|
| Mol Cell Biol 23(15):5269-81. 2003
|
| 56 | CCND1
|
| Cyclin D1 gene (CCND1) mutations in endometrial cancer.
|
| Moreno-Bueno G, Rodriguez-Perales S, Sanchez-Estevez C, Hardisson D, Sarrio D, Prat J, Cigudosa JC, Matias-Guiu X, Palacios J.
|
| Oncogene 22(38):6115-8. 2003
|
| 57 | CCND1
|
| Unusual case of leukemic mantle cell lymphoma with amplified CCND1/IGH fusion gene.
|
| Gruszka-Westwood AM, Atkinson S, Summersgill BM, Shipley J, Elnenaei MO, Jain P, Hamoudi RA, Kaeda JS, Wotherspoon AC, Matutes E, Catovsky D.
|
| Genes Chromosomes Cancer 33(2):206-12. 2002
|
| 58 | CCND1, CCNE1
|
| Hedgehog regulates cell growth and proliferation by inducing Cyclin D and Cyclin E.
|
| Duman-Scheel M, Weng L, Xin S, Du W.
|
| Nature 417(6886):299-304. 2002
|
| 59 | CCND1
|
| Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck.
|
| Akervall J, Borg A, Dictor M, Jin C, Jin Y, Tanner M, Isola J, Mertens F, Wennerberg J.
|
| Int J Oncol 20(1):45-52. 2002
|
| 60 | CCND1, PAX5, TAL1
|
| Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry.
|
| Falini B, Mason DY.
|
| Blood 99(2):409-26. Review. 2002
|
| 61 | CCND1
|
| Cyclin D1 amplification in chromosomal band 11q13 is associated with overrepresentation of 3q21-q29 in head and neck carcinomas.
|
| Jin Y, Jin C, Wennerberg J, Hoglund M, Mertens F.
|
| Int J Cancer 98(3):475-9. 2002
|
| 62 | CCND1, CDH1
|
| Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer.
|
| Porter TR, Richards FM, Houlston RS, Evans DG, Jankowski JA, Macdonald F, Norbury G, Payne SJ, Fisher SA, Tomlinson I, Maher ER.
|
| Oncogene 21(12):1928-33. 2002
|
| 63 | CCND1, TACSTD2
|
| Cyclin D1 gene contains a cryptic promoter that is functional in human cancer cells.
|
| Terrinoni A, Dell'Arciprete R, Fornaro M, Stella M, Alberti S.
|
| Genes Chromosomes Cancer 31(3):209-20. 2001
|
| 64 | CCND1
|
| CYCLIN D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer.
|
| Bala S, Peltomaki P.
|
| Cancer Res 61(16):6042-5. 2001
|
| 65 | BCL2, CCNA1, CCNB1, CCND1, CDKN1A, CDKN2A, MKI67, RB1
|
| Immunohistochemical expression of p53, p21/waf1, rb, p16, cyclin D1, p27, Ki67, cyclin A, cyclin B1, bcl2, bax and bak proteins and apoptotic index in normal thymus.
|
| Kanavaros P, Stefanaki K, Rontogianni D, Papalazarou D, Sgantzos M, Arvanitis D, Vamvouka C, Gorgoulis V, Siatitsas I, Agnantis NJ, Bai M.
|
| Histol Histopathol 16(4):1005-12. 2001
|
| 66 | CCND1, JUN, JUNB
|
| Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression.
|
| Bakiri L, Lallemand D, Bossy-Wetzel E, Yaniv M.
|
| EMBO J 19(9):2056-68. 2000
|
| 67 | CCND1
|
| Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes.
|
| Beier F, et al.
|
| Proc Natl Acad Sci U S A 96 : 1433-1438. 1999
|
| 68 | CCND1
|
| Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells.
|
| Matsumura I, et al.
|
| EMBO J 18(5):1367-1377. 1999
|
| 69 | CCND1, RB1
|
| Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma.
|
| Tominaga Y, et al.
|
| Kidney Int 55(4):1375-83. 1999
|
| 70 | CCND1, CCND2, CCND3
|
| Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) in human malignant gliomas.
|
| Buschges R, et al.
|
| Brain Pathol 9(3):435-42; discussion 432-3 1999
|
| 71 | BCL1, CCND1
|
| Cooperative and differential effects of estrogen, prolactin, 22K and 20K human growth hormones on cyclin D1/PRAD1 gene expression in T-47D human breast cancer cells.
|
| Kaneko H, Fujikawa T, Alam KS, Kaneko S, Tanaka M, Hibasami H, Nakashima K.
|
| Biochem Mol Biol Int 46 : 411-414. 1998
|
| 72 | BCL1, CCND1
|
| Detection of cyclin D1 (bcl-1), PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma.
|
| Uchimaru K, et al.
|
| Blood 89 : 965-974. 1997
|
| 73 | BCL1, CCND1
|
| Visualization of mono-allelic chromosomal aberrations 3' and 5' of the cyclin D1 gene in mantle cell lymphoma using DNA fiber fluorescence in situ hybridization.
|
| de Boer CJ, Vaandrager JW, van Krieken JH, Holmes Z, Kluin PM, Schuuring E.
|
| Oncogene 15(13):1599-603. 1997
|
| 74 | CCND1, CTTN, FGF3
|
| EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer.
|
| Hui R, Campbell DH, Lee CS, McCaul K, Horsfall DJ, Musgrove EA, Daly RJ, Seshadri R, Sutherland RL.
|
| Oncogene 15(13):1617-23. 1997
|
| 75 | BCL1, CCND1
|
| Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma.
|
| De Boer CJ, et al.
|
| Oncogene 10 : 1833-1840. 1995
|
| 76 | CDKN2A, RB1, CCND1
|
| Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.
|
| Lukas J, et al.
|
| Nature 375 : 503-506. 1995
|
| 77 | CCND1, CTTN
|
| The involvement of the chromosome 11q13 region in human malignancies : cyclin D1 and EMS1 are two new candidate oncogenes-a review.
|
| Schuuring E.
|
| Gene 159 : 83-96. 1995
|
| 78 | CCND1
|
| A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line.
|
| Lebwohl DE, et al.
|
| Oncogene 9 : 1925-1929. 1994
|
| 79 | BCL1, CCND1
|
| Rearrangement of CCND1 (BCL1/PRAD1) 3' untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias.
|
| Rimokh R, et al.
|
| Blood 83 : 3689-3696. 1994
|
| 80 | BCL1, CCND1
|
| Identification of a B lymphoid disorder defined by specific morphologic features, a del(11)(q13) and a same breakpoint far from CCND1. (abstr)
|
| Morel D, et al.
|
| Am J Hum Genet 55 : A301. 1994
|
| 81 | BCL1, CCND1
|
| A variant chromosome translocation at 11q13 identifying PRAD1/Cyclin D1 as the BCL-1 gene.
|
| Komatsu H, et al.
|
| Blood 84 : 1226-1231. 1994
|
| 82 | BCL1, CCND1
|
| Molecular cloning of a t(11;14)(q13;q32) translocation breakpoint centromeric to the BCL1-MTC.
|
| Galigue-Zouitina S, et al.
|
| Genes Chromosomes Cancer 11 : 246-255. 1994
|
| 83 | BCL1, CCND1
|
| Chromosome t(11;14)(q13;32) breakpoints in centrocytic lymphoma are highly localized at the bcl-1 major translocation cluster.
|
| Williams ME, et al.
|
| Leukemia 7 : 1437-1440. 1993
|
| 84 | CCND1
|
| PRADI/cyclin DI proto-oncogene : genomic organization, 5' DNA sequence, and sequence of a tumor-specific rearrangement breakpoint.
|
| Motokura T, et al.
|
| Genes Chromosomes Cancer 7 : 89-95. 1993
|
| 85 | CCND1, BCL1
|
| Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma.
|
| Williams ME, et al.
|
| Leukemia 7 : 241-245. 1993
|
| 86 | CTTN, CCND1
|
| Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.
|
| Schuuring E, et al.
|
| Oncogene 7 : 355-361. 1992
|
| 87 | CCND1, CCND2, CCND3, CCND2P, CCND3P
|
| Genomic organization, chromosomal localization, and independent expression of human cyclin D genes.
|
| Inaba T, et al.
|
| Genomics 13 : 565-574. 1992
|
| 88 | CCND1
|
| Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation.
|
| Seto M, et al.
|
| Oncogene 7 : 1401-1406. 1992
|
| 89 | CCND1
|
| A novel cyclin encoded by a bcl1-linked candidate oncogene.
|
| Motokura T, et al.
|
| Nature 350 : 512-515. 1991
|
| 90 | CCND1
|
| Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in begnin parathyroid tumors.
|
| Rosenberg CL, et al.
|
| Oncogene 6 : 449-453. 1991
|
| 91 | CCND1
|
| D11S287, a putative oncogene on chromosome 11q13,is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1.
|
| Lammie GA, et al.
|
| Oncogene 6 : 439-444. 1991
|
| 92 | CCND1
|
| HaeIII polymorphism within 3' untranslated region of PRAD1.
|
| Heighway J.
|
| Nucleic Acids Res 19 : 5451. 1991
|
| 93 | CCND1, BCL1
|
| PRAD1, a candidate BCL1 oncogene : mapping and expression in centrocytic lymphoma.
|
| Rosenberg CL, et al.
|
| Proc Natl Acad Sci U S A 88 : 9638-9642. 1991
|
| 94 | BCL1, CCND1
|
| Human D-type cyclin.
|
| Xiong Y, et al.
|
| Cell 65 : 691-699. 1991
|
| 95 | CCND1
|
| Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma.
|
| Arnold A, et al.
|
| J Clin Invest 83 : 2034-2040. 1989
|